{"nct_id":"NCT00975130","title":"Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)","status":"COMPLETED","status_verified_date":"2017-03","start_date":"2009-09","start_date_type":null,"primary_completion_date":"2011-08","primary_completion_date_type":"ACTUAL","completion_date":"2012-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}